Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AddLife AB | 112,130 | net | 08 May 2026 | tx 26+112,130 |
| Boule Diagnostics AB | 50,631 | net | 08 Feb 2019 | tx 2+50,631 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 May 2026 | PURCHASE | AddLife AB | 5,500 | 141.79 SEK | |
| 16 Feb 2026 | PURCHASE | AddLife AB | 1,000 | 136.75 SEK | |
| 06 Feb 2026 | PURCHASE | AddLife AB | 1,000 | 149.94 SEK | |
| 05 Dec 2025 | PURCHASE | AddLife AB | 800 | 181.70 SEK | |
| 19 Aug 2025 | PURCHASE | AddLife AB | 500 | 166.07 SEK | |
| 16 Jul 2025 | PURCHASE | AddLife AB | 1,200 | 173.49 SEK | |
| 05 Jun 2025 | PURCHASE | AddLife AB | 4,500 | 191.88 SEK | |
| 20 Dec 2024 | PURCHASE | AddLife AB | 1,000 | 135.50 SEK | |
| 24 Oct 2024 | PURCHASE | AddLife AB | 7,130 | 140.22 SEK | |
| 27 May 2024 | PURCHASE | AddLife AB | 7,500 | 114.13 SEK | |
| 19 Feb 2024 | PURCHASE | AddLife AB | 1,000 | 101.50 SEK | |
| 05 Feb 2024 | PURCHASE | AddLife AB | 2,000 | 110.00 SEK | |
| 24 Nov 2023 | PURCHASE | AddLife AB | 1,000 | 89.95 SEK | |
| 07 Nov 2023 | PURCHASE | AddLife AB | 1,000 | 83.10 SEK | |
| 18 Sept 2023 | PURCHASE | AddLife AB | 3,000 | 69.33 SEK | |
| 21 Jul 2023 | PURCHASE | AddLife AB | 1,000 | 81.80 SEK | |
| 08 Jun 2023 | PURCHASE | AddLife AB | 35,000 | 40.00 SEK | deriv |
| 12 May 2023 | PURCHASE | AddLife AB | 1,000 | 129.40 SEK | |
| 24 Mar 2023 | PURCHASE | AddLife AB | 1,500 | 92.80 SEK | |
| 06 Mar 2023 | PURCHASE | AddLife AB | 1,000 | 111.60 SEK | |
| 14 Dec 2022 | PURCHASE | AddLife AB | 2,500 | 114.10 SEK | |
| 31 Oct 2022 | PURCHASE | AddLife AB | 3,000 | 106.70 SEK | |
| 26 Sept 2022 | PURCHASE | AddLife AB | 1,000 | 121.80 SEK | |
| 09 Sept 2022 | PURCHASE | AddLife AB | 1,000 | 135.56 SEK | |
| 08 Sept 2022 | PURCHASE | AddLife AB | 1,000 | 129.60 SEK |
2 purchases reported after at least 12 months of silence — most recent on 02 Sept 2022.